Citius Pharmaceuticals, Inc. (CTXR) bonds
CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.52−0.01 (-1.67%)
Close on Nov 17, 2026Market cap $14.24MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$306.41M
$300.00M due within a year
Net debt
$289.40M
After $17.01M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
-143.9×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
As tagged in Citius Pharmaceuticals's 10-Q for the period ended Jun 30, 2026
Citius Pharmaceuticals's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Loan Agreement | $25.00M |
See a number that looks wrong?